NFE2L2 and neoplasm: Nrf2, key factor of antioxidant systems, was known to be able to protect cells against oxidative stress; improving nuclear translocation of Nrf2 can promote the synthesis and utilization of GSH, and in turn inhibit the proapoptotic effects of ATO on tumor cells (26, 27).